Capital A Wealth Management LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital A Wealth Management LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,003 shares of the medical equipment provider's stock, valued at approximately $1,045,000. Intuitive Surgical comprises about 1.7% of Capital A Wealth Management LLC's holdings, making the stock its 15th largest holding.

Other institutional investors also recently modified their holdings of the company. Onefund LLC raised its stake in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares during the period. AlphaCore Capital LLC raised its stake in Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after purchasing an additional 18 shares during the period. Journey Strategic Wealth LLC raised its stake in Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after purchasing an additional 19 shares during the period. FSM Wealth Advisors LLC raised its stake in Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after purchasing an additional 19 shares during the period. Finally, Parkside Financial Bank & Trust raised its stake in Intuitive Surgical by 2.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider's stock valued at $390,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded down $4.61 on Friday, reaching $551.14. The company had a trading volume of 2,091,011 shares, compared to its average volume of 1,647,905. The firm has a market cap of $197.54 billion, a price-to-earnings ratio of 85.98, a P/E/G ratio of 5.85 and a beta of 1.70. The firm's 50-day moving average price is $516.44 and its two-hundred day moving average price is $538.53. Intuitive Surgical, Inc. has a 1 year low of $396.48 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mark Brosius sold 492 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $282,299.76. Following the sale, the senior vice president now directly owns 4,056 shares in the company, valued at approximately $2,327,251.68. This trade represents a 10.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 30,111 shares of company stock valued at $15,364,055. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent analyst reports. Robert W. Baird decreased their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Barclays decreased their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Evercore ISI decreased their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Finally, Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Five investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.